U.S. flag

An official website of the United States government

NM_001015880.2(PAPSS2):c.1000C>T (p.Arg334Ter) AND Spondyloepimetaphyseal dysplasia, PAPSS2 type

Germline classification:
Pathogenic (4 submissions)
Last evaluated:
Jan 3, 2022
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000007076.11

Allele description [Variation Report for NM_001015880.2(PAPSS2):c.1000C>T (p.Arg334Ter)]

NM_001015880.2(PAPSS2):c.1000C>T (p.Arg334Ter)

Gene:
PAPSS2:3'-phosphoadenosine 5'-phosphosulfate synthase 2 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
10q23.31
Genomic location:
Preferred name:
NM_001015880.2(PAPSS2):c.1000C>T (p.Arg334Ter)
HGVS:
  • NC_000010.11:g.87727403C>T
  • NG_012150.1:g.72685C>T
  • NM_001015880.2:c.1000C>TMANE SELECT
  • NM_004670.4:c.985C>T
  • NP_001015880.1:p.Arg334Ter
  • NP_004661.2:p.Arg329Ter
  • NC_000010.10:g.89487160C>T
  • NM_001015880.1:c.1000C>T
  • NM_004670.3:c.985C>T
Protein change:
R329*; ARG329TER
Links:
OMIM: 603005.0003; dbSNP: rs121908952
NCBI 1000 Genomes Browser:
rs121908952
Molecular consequence:
  • NM_001015880.2:c.1000C>T - nonsense - [Sequence Ontology: SO:0001587]
  • NM_004670.4:c.985C>T - nonsense - [Sequence Ontology: SO:0001587]
Observations:
1

Condition(s)

Name:
Spondyloepimetaphyseal dysplasia, PAPSS2 type
Synonyms:
SEMD, PAKISTANI TYPE; Spondyloepimetaphyseal dysplasia, pakistani type; BRACHYOLMIA TYPE 4 WITH MILD EPIPHYSEAL AND METAPHYSEAL CHANGES
Identifiers:
MONDO: MONDO:0019666; MedGen: C2748515; Orphanet: 93282; OMIM: 612847

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000027272OMIM
no assertion criteria provided
Pathogenic
(May 28, 2009)
germlineliterature only

PubMed (1)
[See all records that cite this PMID]

SCV000807496Baylor Genetics
criteria provided, single submitter

(ACMG Guidelines, 2015)
Pathogenic
(Sep 1, 2017)
germlineclinical testing

PubMed (3)
[See all records that cite these PMIDs]

SCV000926199Oxford Medical Genetics Laboratories, Oxford University Hospitals NHS Foundation Trust
no assertion criteria provided
Pathogenic
(May 3, 2019)
inheritedclinical testing

SCV0020591143billion
criteria provided, single submitter

(ACMG Guidelines, 2015)
Pathogenic
(Jan 3, 2022)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

PMID:19474428

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineyes1not providednot provided1not providedclinical testing
not providedinheritedyesnot providednot providednot providednot providednot providedclinical testing
not providedgermlinenot providednot providednot providednot providednot providednot providedliterature only

Citations

PubMed

Inactivating PAPSS2 mutations in a patient with premature pubarche.

Noordam C, Dhir V, McNelis JC, Schlereth F, Hanley NA, Krone N, Smeitink JA, Smeets R, Sweep FC, Claahsen-van der Grinten HL, Arlt W.

N Engl J Med. 2009 May 28;360(22):2310-8. doi: 10.1056/NEJMoa0810489. Erratum in: N Engl J Med. 2009 Jul 9;361(2):217.

PubMed [citation]
PMID:
19474428

Molecular findings among patients referred for clinical whole-exome sequencing.

Yang Y, Muzny DM, Xia F, Niu Z, Person R, Ding Y, Ward P, Braxton A, Wang M, Buhay C, Veeraraghavan N, Hawes A, Chiang T, Leduc M, Beuten J, Zhang J, He W, Scull J, Willis A, Landsverk M, Craigen WJ, Bekheirnia MR, et al.

JAMA. 2014 Nov 12;312(18):1870-9. doi: 10.1001/jama.2014.14601.

PubMed [citation]
PMID:
25326635
PMCID:
PMC4326249
See all PubMed Citations (3)

Details of each submission

From OMIM, SCV000027272.4

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedliterature only PubMed (1)

Description

For discussion of the arg329-to-ter (R329X) mutation in the PAPSS2 gene that was found in compound heterozygous state in a family segregating brachyolmia type 4 with mild epiphyseal and metaphyseal changes (BCYM4; 612847) by Noordam et al. (2009), see 603005.0002.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlinenot providednot providednot providednot providednot providednot providednot providednot provided

From Baylor Genetics, SCV000807496.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing
(GTR000508680.4)
PubMed (3)

Description

This variant has been previously reported as disease-causing and was found once in our laboratory homozygous in a 7-year-old male with IUGR, failure to thrive, microcephaly, chondrodystrophy, severe kyphoscoliosis, asymmetric chest with rib flaring, mild knee contractures, asymmetric face with maxillary and orbital hypoplasia, dysmorphism, hypotonia, PDA

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot provided
(GTR000508680.4)
not providednot providednot providednot provided

From Oxford Medical Genetics Laboratories, Oxford University Hospitals NHS Foundation Trust, SCV000926199.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1inheritedyesnot providednot providednot providednot providednot providednot providednot provided

From 3billion, SCV002059114.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided1not providednot providedclinical testing PubMed (1)

Description

Stop-gained (nonsense): predicted to result in a loss or disruption of normal protein function through nonsense-mediated decay (NMD) or protein truncation. Multiple pathogenic variants are reported downstream of the variant (PVS1_VS). It is observed at an extremely low frequency in the gnomAD v2.1.1 dataset (total allele frequency: 0.000036, PM2_M). The variant has been reported at least twice as pathogenic/likely pathogenic with clinical assertions and evidence for the classification (ClinVar ID: VCV000006688, PMID:19474428). Therefore, this variant is classified as pathogenic according to the recommendation of ACMG/AMP guideline.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyes1not providednot provided1not providednot providednot provided

Last Updated: Jun 23, 2024